Topics
Sector
Geography
Subject

Videos Library

All Videos

1586
videos of thought-leading presentations and interactive panel discussions from life science industry visionaries and experts

The NextLevel LifeSciences Videos Library is the full collection of video recordings (and supporting documentation) from all NextLevel LifeSciences events.

Latest Videos

Presentation

Medical communications: Integrating the patient voice

Related topics: Medical Affairs & Stakeholder Engagement, Global (non-specific), Patient-Centricity & Care, Life Sciences (not-specific)
Availability: FREE
  • Identify key questions that should be asked when determining if medical communications are meaningful for patients.
  • Working with stakeholders to provide insights for patient-centric communications.
  • Describe two case studies that demonstrate how medical communications to patients were vastly improved by applying patient insights.
Speaker

William C Maier
Chief Scientific Officer and Head of Patient-Centered Sciences
Mapi Group

Presentation

Achieving world class execution in medical affairs

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Life Sciences (not-specific)
Availability: FREE
  • Transformation of medical affairs to deliver greater value.
  • Executing long term engagement strategies in today’s complex disease space.
  • Developing and delivering scientific insights to achieve strategic differentiation.
Speaker

Sital Kotecha
Director, Medical Strategy
Veeva Systems, UK

Presentation

Future market access excellence: Enabling a dynamic organisation

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Global (non-specific), Capabilities & Effectiveness
Availability: FREE
  • New organisational capability needs to address major market changes.
  • Optimising global strategy and local agility: Updated planning and governance structures.
  • Cross-functional leadership and aligned KPIs.
  • Digital tools to drive efficiency, effectiveness and feedback.
Speaker

Chris Easley
Head of Market Access Solutions
Pope Woodhead and Associates Ltd.

Presentation

What’s it worth to you? Assessing value of product attributes through decision-analytic modelling

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Global (non-specific)
Availability: FREE
  • How a product’s characteristics or attributes contribute to both individual willingness to pay and “value” from different perspectives (e.g., stakeholder, society).
  • The various methodologies through which attribute value can be assessed.
  • A real-world case study of how decision-analytic modelling helped a leading medical device company establish the value of a unique product attribute, and by so doing justify higher tender pricing in a key EU market.
Speaker

Mason W. Russell
Vice President, Strategic Consulting (Life Sciences)
Truven, USA

Presentation

Why a good strategy is not enough

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Global (non-specific), Capabilities & Effectiveness
Availability: FREE
  • Organisational excellence provides the bridge from strategy to results.
  • What are the building blocks of the bridge and what gets missed.
  • How should we apply organisational excellence to market access strategy.
  • What can we learn from other industries?
Speaker

Janice Haigh
Vice President, Pricing & Market Access
PAREXEL

Presentation

Payer Trackers: A unique opportunity to shift the market access mindset from one of observing to one of shaping payer attitudes

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Global (non-specific)
Availability: FREE
  • Understanding payer attitudes to optimise business performance.
  • What is the optimal reach and frequency of a payer tracker to maximise impact of such an approach.
  • How can payer trackers can be utilised to leverage business performance.
  • Benefit of payer trackers when sharing information with key internal stakeholders.
Speaker

Santanu Das
Vice President
GFK, UK

Presentation

What is the Future for International Reference Pricing (IRP)

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Global (non-specific)
Availability: FREE

Most developed countries apply some form of IRP as a factor in negotiating or regulating domestic pricing. With the emergence of risk sharing agreements and in particular confidential price / volume agreements tied to HTA assessments some experts are suggesting the end of IRP systems in imminent. In contrast, some countries like Canada are placing greater reliance on IRP to lower drug prices.

  • Beginnings and Evolution of IRP.
  • Overview of approaches to IRP.
  • Impact of IRP on product launches and HTA.
  • Role of risk-sharing agreements to mitigate impact of IRP.
  • Canadian IRP as a case study.
Speaker

Neil Palmer
Founder & Senior Consultant
PDCI Market Access

Presentation

Digital technology: An enabler of patient, payer and physician engagement

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Medical Affairs & Stakeholder Engagement, Patient-Centricity & Care, Digital & Technology
Availability: FREE
  • The revolution has already happened in other sectors: Is health next?
  • How is digital technology being deployed along the health value chain?
  • How will technology change patient, physician and payer engagement?
  • Can technology radically change data collection and analysis in clinical trials and the real world and therefore the assessment of value?
Speaker

Giles Thurston
Head of Digital Solutions
Pope Woodhead and Associates Ltd.

Presentation

The impact of PROs on HTA decision-making

Related topics: Pharmaceutical/Biotech, Europe, Market Access & HEOR
Availability: FREE
  • Current perception of PRO evidence among payers and its influence in decision-making 
  • Differences between payer and regulators in assessing PRO evidence
Speaker

Anke van Engen
Principal, Consulting Services
QuintilesIMS

Presentation

Is there a need for a centralised, European HTA agency and predictable, transparent European standards?

Related topics: Pharmaceutical/Biotech, Europe, Market Access & HEOR
Availability: FREE
  • How similar are HTA agencies in methods and procedures?
  • Is there a development towards shared standards?
  • What are stakeholders doing to encourage harmonisation/standardisation?
  • Is there a need for a European institution to get the job done?
Speaker

Finn Boerlum Kristensen
Managing Director Science & Policy, Faculty of Health Sciences, University of Southern Denmark
Former EUnetHTA Executive, Committee Chairman and EUnetHTA Secretariat Director

Presentation

The role of MSLs in the development of pre-market communications

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Commercial, Global (non-specific), Medical Science Liaison, Life Sciences (not-specific)
Availability: FREE
  • Medical Affairs and MSL synchronicity: Linking efforts to ensure a positive outcome.
  • MSLs and KOLs: The data sweet spot: Finding balance within the current regulatory environment.
  • The role of MSLs in audience engagement: Strategic & tactical approaches to engagement.
  • MSL-directed educational communications: An appropriate path forward.
  • Measuring the impact of MSL-driven activities: Applying metrics to establish impact.
Speaker

Tim Day
Principal 
Innovative Strategic Communications

Presentation

Achieving world-class execution in medical affairs

Related topics: Pharmaceutical/Biotech, USA, Medical Affairs & Stakeholder Engagement, Global (non-specific), Life Sciences (not-specific)
Availability: FREE

With the rise of medical affairs as healthcare’s core scientific partner, industry leaders are reimagining their organizations to achieve a world-class standard–and deliver greater value. Learn how to align engagement strategies to healthcare stakeholders’ scientific goals and interests, based on actionable insights.

Speakers

Robert Groebel 
Vice President - Global Medical Strategy 
Veeva

Brian Harper
Senior Director, Medical Content Strategy
Veeva 

Presentation

The Patient as the Payer: What drives patients’ willingness-to-pay?

Related topics: Pharmaceutical/Biotech, Europe, Market Access & HEOR, Patient-Centricity & Care
Availability: FREE
Speaker

Adrien Gras
Vice President Europe, Market Access
GFK, UK

Presentation

Bio-similar, but different: Establishing (or defending) value through Multi-Criteria Decision Analytic (MCDA) modelling

Related topics: Pharmaceutical/Biotech, Europe, Market Access & HEOR, Biosimilars
Availability: FREE
  • How the complex characteristics of biologics (and biosimilars) contribute to perceived value to different stakeholders.
  • The salient issues facing Upstarts (marketers of biosimilars) and Defenders (marketers of “original” biologics) in communicating comparative worth to stakeholders.
  • How MCDA modelling methods can assist both groups in better defining and communicating value.
Speaker

Mason W. Russell
Vice President, Strategic Consulting (Life Sciences)
Truven, USA

Presentation

HTA in the changing development and regulatory landscape

Related topics: Pharmaceutical/Biotech, Europe, Market Access & HEOR
Availability: FREE
  • What is driving changes such as conditional market authorisation and adaptive pathways?
  • What are the challenges for HTA agencies and their evaluation approaches?
  • What are the critical success factors for pharma companies?
Speaker

Anke van Engen
Principal, Consulting Services
QuintilesIMS

Presentation

Building the market to gain market access in Asia-Pacific countries: From a transactional player to a strategic partner

Related topics: MedTech, Market Access & HEOR, Asia Pacific
Availability: FREE
  • What value does your technology bring to address the needs of the country’s health system?
  • How can you develop the market to create a receptive and favorable environment for your technology?
  • Case study: Established vs. emerging markets.
Speaker

Anne Smart
Director
Navigant, USA

Presentation

Gamification and mobile reinforcement: How science from Harvard Medical School is driving a new approach to healthcare training

Related topics: MedTech, Commercial, Global (non-specific), Digital & Technology
Availability: FREE
  • Ground breaking technology from Harvard Medical School.
  • Used by life science sales teams and healthcare professionals.
  • Extend retention of complex processes and facts from weeks to years.
  • Mobile and social gaming methods to drive adoption and motivation.
  • Maximise return on investment in product training.
     
Speaker

Louella Morton
VP International Sales & General Manager
Qstream

Presentation

Accelerating sales with sales driven marketing

Related topics: MedTech, Commercial
Availability: FREE

In today’s digital age, marketers can use marketing automation and analytics technology enabling them to be hyper-relevant to the customer via online channels. But what happens when the customer schedules a call or meeting with your sales team? How do you know whether or not your content performs well during this offline phase of the customer journey? Learn how to grow your business by supporting your sales and indirect channels with sales driven marketing.

Speaker

Pieterjan Bouten
Chief Executive Officer
Showpad, Belgium

Presentation

Roadmap to market access: Demonstrating value to purchasers

Related topics: MedTech, Market Access & HEOR, Commercial, Global (non-specific)
Availability: FREE
  • Analysis of the real case of a global medical device companythat launched an innovative device to prevent seriouscomplications of a disease and was facing significant market barriers across Europe.
  • In spite of the product’s clinical benefits, commercial teams couldnot quantify the value of the product to purchasers and decisionmakers.
  • The solution came with the development of a process positioningthe best product evidence to directly address the clinical andeconomic needs of stakeholders.
  • Commercial teams were able to quickly demonstrate and quantifyvalue, helping hospitals and clinics to understand the costs and benefits of adopting the medical innovation.
Speaker

Ernesto M. Nogueira 
Managing Director
ValueConnected, Netherlands

Presentation

Effectively incorporate communications in product commercialisation

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific)
Availability: FREE
  • Developing and implementing a scientific strategy to effectively disseminate evidence and show value and engaging with diverse stakeholders.
  • Understanding how, when, and to whom you communicate evidence.
  • Benefits and challenges of consistent communications.
Speaker

Gillian Boucher
Director, Medical Writing and Editorial
Quintiles

Presentation

What do we call KOLs if we can’t call them “KOLs”?

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific)
Availability: FREE
  • The term “KOL”: Too toxic for everyday use, or still the best tool for the job?
  • Results from a survey of pharma and KOLs on the use of terminology alternatives.
  • Should pharma work towards using one universal replacement for the term “KOL”?
  • How does this change the way we engage with KOLs and stakeholders in medical affairs?
  • And what exactly do KOLs think of all this?
Speaker

Sanjay Singhvi  
​Director
System Analytic, UK

Presentation

Quality not quantity in observational research: Delivering the right studies at the right time in the right way to meet your real world evidence needs

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Global (non-specific)
Availability: FREE
  • Defining quality in the context of today’s observational research needs.
  • Developing a framework to deliver quality every time you conduct non-interventional studies.
Speaker

Louise Parmenter 
Global Head of Operations, Epidemiology & Outcomes Research
Real-World & Late Phase Research
Quintiles

Presentation

MSL Technology Showcase

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific), Digital & Technology, Medical Science Liaison
Availability: FREE
Speaker

Gijs Hubben
CEO
BaseCase, Germany

Presentation

Flexible resourcing & talent management models for medical affairs teams

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific)
Availability: FREE
  • Evaluating and developing a medical affairs team’s skill sets for more flexibility.
  • Developing a life-cycle dependent model for flexible medical affairs resourcing.
  • The impact of a flexible resourcing approach on talent acquisition.
  • The role of strategic outsourcing for medical affairs.
Speaker

Keith Morris
Vice President, Medical Affairs
Campbell Alliance, USA

Presentation

Multilateral recruitment approach for early phase oncology trials: Weights and balances

Related topics: Pharmaceutical/Biotech, Clinical, Global (non-specific), Oncology
Availability: FREE
  • Key challenges in early phase oncology recruitment.
  • Therapeutic, supportive and other compounds from trial management perspective.
  • Pros and cons of early phase trials for the investigator and for the cancer patient.
  • Role and potential of professional CPU (Clinical Pharmacology Unit) within indication.
  • Satellite Centre Concept for proper recruitment and controlled quality.
Speaker

Istvan Udvaros 
Medical Director, Project Director of Oncology
SGS LSS Clinical Research, Belgium

Presentation

Mass balance/ADME studies in oncology patients: Successful answers to the challenge in Central and Eastern Europe

Related topics: Pharmaceutical/Biotech, Europe, Clinical, Central Eastern Europe, Oncology
Availability: FREE
  • Patient pharmacology services: Concept and operational set up.
  • ADME concepts, incl. micro-dose and tracer-dose.
  • Underlying dossier requirements incl. preclinical safety package.
  • General design considerations incl. radiodose and radioburden calculation.
  • Devil is in the details: Operational challenges.
  • Selection of geographic region and patient population.
  • Ethical aspects.
Speaker

Agnes Rethy 
Associate Director of Clinical Operations
EDS Patient Pharmacology Services
PRA Health Services

Presentation

A matter of perspective: Evolving the MSL role for the long-term development of next-generation KOLs

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific), Medical Science Liaison
Availability: FREE
  • What is the role of an MSL today in developing strategic relationships with KOLs.
  • Learn what a typical ‘day in the life’ of an MSL is like.
  • Is the role of an MSL here to stay for the long term?
Speaker

Sital Kotecha
Medical Strategy Director, Europe
Veeva Systems, UK

Presentation

Pre-Market Communications: Reaching your audience in today’s complex environment

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific)
Availability: FREE
  • The importance and benefits of an effective pre-market communication plan.
  • The when, where and how of the various elements who need to be engaged.
  • Development and implementation of the plan: Where the magic happens and results are driven!
  • The essential elements to any pre-market communication plan.
  • The need for achieving balance between the speed, timing and volume of pre-market communications.
Speaker

Tim Day
CEO & Principal
Innovative Strategic Communications, USA

Presentation

RWE: The good, the bad and the necessary

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Global (non-specific)
Availability: FREE
  • A review of success rates in recent drug launches.
  • Look at where launches haven’t gone well and where RWE could have played a role in mitigating this: The bad.
  • Building an Integrated Medical Plan to prepare for success (Begin with the end in mind): The good.
  • The resource vs. demand challenge and the consequent benefit of outsourcing: The necessary.
Speaker

Alistair MacDonald
Executive Director, Real World Strategy
INC Research, UK

Presentation

Integrating real-world evidence into global market access planning

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Global (non-specific)
Availability: FREE
  • Regulators and payer considerations of the ‘key value drivers’ in RWE generation.
  • Highly successful RWE strategies, study designs and best practices and how they differ across global markets.
  • How medical affairs can best utilise RWE to support market access decision making.
Speakers

Leanne Larson
Vice President and Global Head, Observational Research
Parexel, USA

Oliver Leatham
Vice President and Head, Pricing and Market Access
Parexel, UK

Presentation

Applying the patient perspective to medical planning

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific), Patient-Centricity & Care
Availability: FREE
  • Apply a single framework for patient centricity in medical affairs.
  • Uncover what patients value and how it changes on their treatment journey.
  • Structure and prioritise innovative medical activities in a patientcentric way.
Speaker

Dominic Sloane 
Development Director
Adelphi Communications, United Kingdom

Presentation

Getting to world class medical affairs

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific), Digital & Technology
Availability: FREE
  • Challenges facing medical affairs functions today.
  • Medical affairs transformation as pipelines shift to specialty care.
  • Getting to ‘world class’ through focus on delivering an exceptional stakeholder experience.
Speaker

Sital Kotecha 
Medical Strategy Director, Europe
Veeva Systems, UK

Presentation

Success case study: Driving bottom-line surge using salesforce analytics, salesforce sizing and deployment issues

Related topics: MedTech, Commercial, Global (non-specific)
Availability: FREE
  •  Promotion response modelling for ROI on sales calls to derive optimal size.
  •  Territory alignment based on Potential Index and Workload Index.
  •  Incentive design for salesforce based on fairness, motivation and financial risk.
Speaker

Sumit Mehta
Managing Director
Cetas Healthcare Insights

Presentation

Improving commercial effectiveness at scale: A Boston Scientific case study

Related topics: MedTech, Commercial, Global (non-specific)
Availability: FREE
  •  Identifying commercial learning challenges.
  •  Shifting middle performers.
  •  Implementing solutions to support continuous commercial learning at scale.
  •  The path to continued commercial effectiveness.
Speakers

Jay Bratcher 
Training Manager, New Cardio, Europe 
Boston Scientific, UK

Michael Quann
Director Strategic Account
Qstream, Ireland

Presentation

How reimbursement/funding drive sales and adoption for medical technologies?

Related topics: MedTech, Market Access & HEOR, Commercial, Global (non-specific)
Availability: FREE
  • Overview of the main reimbursement systems in Europe.
  • Price: The main barrier for medical technology.
  • When is it (really) necessary to apply for reimbursement?
  • Demonstrating value to access healthcare payment pathways.
  • Moving ahead: The new EU perspective on medical innovations.
Speaker

Ernesto Nogueira
Managing Director 
ValueConnected

Presentation

CPQ and Tender Management: How can I optimise my commercial strategy?

Related topics: MedTech, Market Access & HEOR, Commercial, Global (non-specific)
Availability: FREE

Prioritising and targeting the best business opportunities is crucial for medical device
companies to create an optimal offering strategy while controlling and minimising
discounting. Therefore it is critical for global pricing, commercial and marketing
leaders to standardise their price configuration, quotes and tender processes with
best practices. This approach will lead to new business and optimal deal structures,
resulting in higher revenues and margins.

Speaker

James Robinson
Director Industry Solutions
ModelN, Switzerland

Presentation

The importance of achieving recruitment targets in MENA

Related topics: Pharmaceutical/Biotech, Clinical, Middle East
Availability: FREE
  •  Why is recruitment important?
  •  Issues seen in studies (generally not just MENA).
  •  What are the possible reasons for this?
  •  Are there differences between MENA and ROW in patient recruitment numbers and retention rates?
  •  How could we actively prevent these issues?
  •  Case studies (both good and bad) & lessons learned.
Speaker

Myriam El-Khazen
General Manager 
INC Research, Greece

Presentation

Mapping real-world centers: Can it be done?

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Asia Pacific
Availability: FREE
Speaker

Karen Wai
Vice President, Regional Managing Director Real-World & Late Phase Research, Asia Pacific
Quintiles, Singapore

Presentation

RWE in Asia: Has its time finally come?

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Asia Pacific
Availability: FREE
  •  Current state of RWE in Asia markets.
  •  Key trends and how it is evolving.
  •  What this means for healthcare companies.
Speaker

Sheryl Jacobson
Asia Head of Life Science and Healthcare Consulting 
Deloitte

Presentation

Opportunities and challenges using unsolicited, self-reported, health outcomes data from open web-based media sources

Related topics: Pharmaceutical/Biotech, IT & Big Data, Global (non-specific), Digital & Technology
Availability: FREE
  • An ever-increasing number of individuals routinely contribute and consume solicited and unsolicited information about a variety of health-related issues using a wide range of internet and social media channels.
  • Personal web-based reports on health status, symptoms, treatments and associated interventions may provide a rich source of data to support discovery, clinical development and post marketing analytics.
  • A key challenge in the applicability and utility of these data is related to the veracity, accuracy and reliability of information collected from web-based media sources.
Speaker

Mark Wolff
Advisory Industry Consultant, Chief Health Analytics Strategist
Health & Life Sciences Global Practice, SAS Institute, USA

Presentation

Leading patient engagements: From patient data analytics to mHealth interventions

Related topics: Pharmaceutical/Biotech, IT & Big Data, Global (non-specific), Patient-Centricity & Care, Digital & Technology
Availability: FREE
Speaker

Alexander Frenzel
Senior Manager, Business Development T&A, QuintilesIMS, Germany

Presentation

Bridging the gap between good science and clinical application

Related topics: Pharmaceutical/Biotech, Clinical, IT & Big Data, Discovery & R&D Innovation, Global (non-specific)
Availability: FREE
Speaker

Jonathan Sheldon
Global Vice President, Healthcare | Health Sciences
Global Business Unit, Oracle Health Sciences, UK

Presentation

Optimising clinical trial design and execution using Real-World Data and Predictive Analytics

Related topics: Pharmaceutical/Biotech, Real-World Evidence & Late-Phase Research, Clinical, IT & Big Data, Global (non-specific)
Availability: FREE
Speaker

John Rigg
Head of Predictive Analytics Real-World Insights, QuintilesIMS, UK

Presentation

Demystifying Artificial Intelligence for Pharma in the Era of Big Data

Related topics: Pharmaceutical/Biotech, IT & Big Data, Discovery & R&D Innovation, Global (non-specific)
Availability: FREE
  • Convergence of data, technology and advances in the field ofneural networks.
  • Increased opportunities for the use of real-world evidence data sets from the genome revolution, clinical trials, medical imaging and electronic health records.
  • Accelerate the use of Artificial Intelligence (AI) within Pharma R&D to develop actionable insights.
Speaker

Andrea de Souza
Global Business Development Lead, NVIDIA, USA

Presentation

How deep data and predictive analytics can enhance R&D portfolio management

Related topics: Pharmaceutical/Biotech, Clinical, IT & Big Data, Discovery & R&D Innovation, Global (non-specific)
Availability: FREE
  • Identify new patient target groups for innovative drug development by applying predictive analytics to real world and trial data.
  • Enhance R&D productivity by mapping the real world using predictive analytics.
  • Facilitate the implementation of Adaptive Pathways through predictive analytics.
Speakers

Kerstin Bode-Greuel
Dir. Business Development & Marketing RWE
QuintilesIMS, Germany

Rolf Günther
Chief Information Officer
Qlaym Healthcare, Germany

Presentation

HTA, funding & reimbursement of cell & gene therapies: A global perspective

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Global (non-specific)
Availability: FREE
  • Health technology assessment challenges in assessing clinical and cost effectiveness of cell / gene therapies.
  • Who pays? Healthcare system determinants of funding/reimbursement paradigm.
  • Affordability: Pricing and budget impact challenges
Speaker

W. Neil Palmer
President & Principal Consultant
PDCI Market Access Inc.

Presentation

Central and Eastern Europe: Diversity to tame, market access potential to unveil

Related topics: Pharmaceutical/Biotech, MedTech, Europe, Market Access & HEOR, Central Eastern Europe
Availability: FREE
  • Regional diversities in approaches to public funding decision making.
  • Comparative measures to enable informed allocation of company strategic efforts.
  • Analysis of public funding decision making practice as a tool to identify risks and opportunities and to provide unbeatable arguments to CEE decision makers
Speaker

Norbert Wilk
Director, Market Access Consulting
Arcana Institute, Poland

Presentation

Devising value-enhancing strategies for biosimilars: A conceptual framework

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Biosimilars
Availability: FREE
  • Is differentiation possible or even necessary in the biosimilars market? Although the impetus for a biosimilar development originally might have been solely economic, we argue thatmmanufacturers should devise a value proposition for biosimilars that moves beyond price, demonstrating value to payers, physicians, and patients.
  • Presenting a unifying value framework as a guiding tool for biosimilar manufacturers supporting internal processes - for example: Building internal business cases for differentiating concepts with the end goal to develop a value-enhancing strategy.
Speaker

Sotiris Rompas
Director
Boston Healthcare, USA

Presentation

Biologics, biosimilars, and interchangeable biologics: US update after first launch

Related topics: Pharmaceutical/Biotech, USA, Market Access & HEOR, Biosimilars
Availability: FREE
  • The US is essentially a “secondary” market for biosimilars; as such, what can be learned from other markets?
  • The business model for biosimilars, neither branded or generic products, is likely to be different in the US than in other markets, especially when it comes to pricing. How will business models be structured and operate?
  • With only 5 applications and 1 approval to date, there isn’t yet a clear regulatory pathway for biosimilars in the US. What might that pathway look like when more fully developed?
  • With originators of branded products making more defensive manoeuvres in the US than in other countries, lifecycle management of biosimilars is likely to be different in the US than elsewhere. What differences will there be?
Speaker

Kathleen E. Hughes
Vice President, Avalere Health, USA

Presentation

Blueprint for market access: Strategic insights from the regulatory and HTA review process

Related topics: Pharmaceutical/Biotech, Europe, Market Access & HEOR
Availability: FREE

An interactive session exploring the lifecycle of a drug including:

  • Comparison of regulatory and HTA agency clinical trial evaluations
  • Impact of the label indications on the HTA review process
  • HTA opinion on submitted evidence
Speaker

Yin Ho
CEO
Context Matters Inc., USA

Register to view both free videos and browse premium content (and event documentation).

1586
videos of thought-leading presentations and interactive panel discussions from life science industry visionaries and experts
300+
new videos added every year!